Paper16636233
Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.
Davis SM and 8 others. Neurology, 2006. Cited by 908 papers, by iCite.
Cite this record
ConductScience Library. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Papers, record 16636233. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16636233
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cerebral Hemorrhage | Major topic |
| Hematoma, Subdural | Major topic |
| Aged | |
| Factor VII | |
| Factor VIIa | |
| Female | |
| Humans | |
| Male | |
| Prognosis | |
| Recombinant Proteins | |
| Risk Factors | |
| Tomography, X-Ray Computed |
Source PubMed
Trials4
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00426803 | Recombinant Factor VIIa in Acute Intracerebral Haemorrhage | Results | ClinicalTrials.gov | |
| NCT01202864 | Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) | Background | ClinicalTrials.gov | |
| NCT01472224 | Volume Measurement and Progression Surveillance of Intracerebral Haemorrhage Using Transcranial Ultrasound | Background | ClinicalTrials.gov | |
| NCT05118997 | Active Removal of IntraCerebral Hematoma Via Active Irrigation | Background | ClinicalTrials.gov |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 17283327 | Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. | https://conductscience.org/library/papers/17283327 |
Source PubMed
Cited by447
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 908 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42983649 | A multimodal Vision-Mamba model based on non-contrast CT hematoma and shell features predicts early hematoma expansion in hypertensive intracerebral hemorrhage: a multicenter study. | BMC Med Imaging | 2026 | https://conductscience.org/library/papers/42983649 | PubMed |
| 42864513 | Use of Desmopressin in Spontaneous Nontraumatic Intracerebral Hemorrhage Among Patients Taking Antiplatelet Therapy: Systematic Review and Bayesian Meta-analysis. | Neurocrit Care | 2026 | https://conductscience.org/library/papers/42864513 | PubMed |
| 42779188 | Factors Associated With 90-Day Functional Outcome After Neurosurgical Management of Hypertensive Intracerebral Hemorrhage. | Brain Behav | 2026 | https://conductscience.org/library/papers/42779188 | PubMed |
| 42761090 | Construction of an interpretable prediction model for poor functional outcome in conservatively managed basal ganglia hemorrhage based on CT radiomics and multiple machine learning algorithms. | Front Neurol | 2026 | https://conductscience.org/library/papers/42761090 | PubMed |
| 42689324 | Cilostazol Treatment for Intracerebral Hemorrhage: Targeting Dural Lymphatics. | Stroke | 2026 | https://conductscience.org/library/papers/42689324 | PubMed |
| 42652604 | TeleKap-Supported Intracerebral Haemorrhage Care in Slovenia: Organisational Framework, Potential Benefits, and Evidence Gaps. | J Clin Med | 2026 | https://conductscience.org/library/papers/42652604 | PubMed |
| 42601546 | CT-based prediction of hematoma expansion and adverse outcomes after intracerebral hemorrhage: evidence appraisal, artificial intelligence translation, and GeroScience perspectives. | Geroscience | 2026 | https://conductscience.org/library/papers/42601546 | PubMed |
| 42525110 | The frequency and predictors of hematoma expansion in wake-up intracerebral hemorrhage. | Neurol Sci | 2026 | https://conductscience.org/library/papers/42525110 | PubMed |
| 42477258 | Effect on Mortality of Anticoagulant Reversal in Acute Intracranial Hemorrhage: A Systematic Review and Meta-analysis. | Neurocrit Care | 2026 | https://conductscience.org/library/papers/42477258 | PubMed |
| 42396236 | Current evidence and future directions for prophylactic anticoagulation therapy after severe spontaneous intracerebral hemorrhage: a narrative review. | J Intensive Med | 2026 | https://conductscience.org/library/papers/42396236 | PubMed |
| 42355680 | Is FIB-4 Index an Independent Risk Factor for Hematoma Expansion in Acute Intracerebral Hemorrhage? A Retrospective Multicenter Observational Cohort Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/42355680 | PubMed |
| 42318415 | Research on predicting risk factors for re-bleeding in the acute phase of intracerebral hemorrhage using machine learning algorithms. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42318415 | PubMed |
| 42294608 | Two Decades of Therapeutic Trials in Supratentorial Intracerebral Haemorrhage: Lessons from Failure and Success. | Expert Rev Mol Med | 2026 | https://conductscience.org/library/papers/42294608 | PubMed |
| 42272357 | Optimising hyperacute intracerebral haemorrhage management: factors influencing timely intervention. | Intern Med J | 2026 | https://conductscience.org/library/papers/42272357 | PubMed |
| 42251221 | Reducing Inequalities in Stroke Events-Hemorrhagic Disparities (RISE-HD): a 10-Year Longitudinal Study in Florida. | J Racial Ethn Health Disparities | 2026 | https://conductscience.org/library/papers/42251221 | PubMed |
| 42221216 | Prognostic Value of the C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index for In-Hospital Mortality in Spontaneous Intracerebral Hemorrhage: A Comparative Analysis with Hematoma Volume. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42221216 | PubMed |
| 42180010 | Functional outcome prediction across multiple timescales intracerebral hemorrhage using a radiomics model. | Eur J Radiol Open | 2026 | https://conductscience.org/library/papers/42180010 | PubMed |
| 42132170 | Location-Specific Hematoma Volume Tolerance for Spontaneous Intracerebral Hemorrhage: A Pooled Analysis of INTERACT2 and ATACH II. | J Am Heart Assoc | 2026 | https://conductscience.org/library/papers/42132170 | PubMed |
| 42131511 | Immune cells in intracerebral hemorrhage. | Brain Hemorrhages | 2025 | https://conductscience.org/library/papers/42131511 | PubMed |
| 42093656 | Predictors of Hematoma Expansion and Response to Andexanet in Patients With Intracerebral Hemorrhage: Secondary Analyses of the ANNEXA-I Randomized Clinical Trial. | Stroke | 2026 | https://conductscience.org/library/papers/42093656 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16636233
GET https://conductscience.org/api/papers/v1/16636233/cited_by?page=2